Fundly.ai raises $4M equity round to expand digital pharma distribution in India
Mumbai-based Fundly.ai has raised $4 million in equity funding led by Accel and Multiply Ventures, alongside about $0.9 million in venture debt. The startup plans to scale digital commerce, payments and embedded credit tools for pharma retailers and distributors across India.
What happened
Mumbai-based B2B pharma distribution startup Fundly.ai raised $4 million led by Accel and Multiply Ventures, plus about $0.9 million in venture debt. It will
Key facts
- $4 million equity funding
- approximately $0.9 million venture debt
- $3 million seed funding in 2023
- Founded in 2021
Why this matters
Pharma distributors, fintechs and healthcare platforms should view Fundly.ai as an increasingly funded potential partner or competitor in digitizing trade workflows, retailer credit and procurement across India.
What to watch
- Growth in active pharmacies, distributors, repeat-order frequency and gross merchandise value.
- Share of platform transactions using embedded credit and changes in repayment, delinquency or collection metrics.
- New city launches, distributor exclusivity agreements or integrations with pharmacy-management software.
- Follow-on funding, expansion of venture-debt facilities or hiring in credit-risk and collections teams.
- Pricing and product responses from B2B pharma commerce platforms, distributors and digital-health supply-chain competitors.
- Expand pharmacy and distributor onboarding beyond Mumbai into high-density urban and tier-2 pharma markets.
- Use venture debt primarily for working-capital and receivables financing rather than fixed-cost expansion.
- Build credit underwriting from transaction, repayment and inventory-purchase data collected through the commerce platform.
- Pursue integrations with medicine distributors, wholesalers, ERP providers and payment rails to increase daily workflow stickiness.
- Measure contribution margins by retailer cohort before aggressively subsidizing credit or delivery.